GlobeNewswire by notified

Crocus Technology Expands High Precision Portfolio of Isolated Current Sensors over Industrial and Automotive Temperature Ranges

Share

The CT425 family of XtremeSense® TMR products offers high accuracy isolated current sensing with Common Mode Field Rejection at 1 MHz bandwidth

SANTA CLARA, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Crocus Technology Inc., the leading supplier of disruptive Tunnel Magneto-Resistance XtremeSense® sensors, today announces the CT425, CT426, CT427 and CT428 isolated current sensors with <1% total error over the full operating temperature range without sacrificing accuracy or bandwidth. The high-speed operation and accurate output allow customers to optimize system design for smaller size and higher efficiency.

The CT42x with less than 300 ns response time greatly simplifies the solution in EV Charging applications which are utilizing GaN (Gallium Nitride) or SiC (Silicon Carbide) transistors to improve power density. Likewise, the CT42x offers improvements in terms of performance and size compared to the classic isolated current sense solutions which utilize a shunt resistor, amplifier, and digital isolator to sense the voltage and convert this signal into a current measurement. The CT42x directly senses the flow of current through the package avoiding errors in conversion and provides inherently faster and more accurate measurements. With industry leading response time of 300 ns, high power architectures like the CCM Totem-Pole PFC can provide higher power density solutions. The fast switching frequency of Wide Bandgap (WBG) power devices requires a current sensor that can detect fast transients to prevent potential cascading failures. The integration in a space saving SOIC-8 package also reduces the total PCB footprint size by up to 8 times smaller compared to existing solutions.

The CT42x has robust built-in immunity to common-mode fields which allows the device to reject greater than 99% of external stray magnetic fields without the need for external shielding while maintaining <1% total accuracy. Crocus’ proprietary TMR technology inherently offers a very high signal-to-noise ratio (SNR) which allows for high resolution measurements required for precision control or monitoring applications.

“The expansion of this product family brings more options to our customers to experience the high precision performance of our XtremeSense TMR products in more demanding applications,” states Zack Deiri, President and CEO of Crocus Technology. “Previously our customers would select products that offered them good performance on one parameter over temperature and then they would adjust their design to compensate for the other parameters. With Crocus products they are finding they can achieve high precision and high bandwidth offering them a comprehensive high performance solution.”

Product features and performance:

CT425 & CT428 (5.0 V version), CT426 & CT427 (3.3 V version)

Integrated 0.5 mΩ conductor enabling 20 A to 65 A AC and DC applications

Total output error ±0.5% FS (typ)

300 ns response time, 1 MHz bandwidth

Rated Isolation Voltage: >4 kVRMS

AEC-Q100 & UL/IEC 62368 Certified, IEC 61000-4-5 Certified

Over current detection (CT427 & CT428), Enhanced filter (CT425 & CT426)

Integrated Common Mode Field Rejection (CMFR) with > 99% immunity

Targeting applications in Power-Factor Correction (PFC), Solar Power Inverters, Battery Management Systems (BMS), xEV Chargers, DC/DC converters and AC/DC inverters.

The CT425, CT426, CT427 and CT428 sensors are available in an industry standard SOIC-8 package. Samples and evaluation boards are currently available. For more information on the CT42x product family, please visit the product webpage:

https://crocus-technology.com/products/ct42x/

About Crocus Technology

Crocus Technology develops and manufactures state-of-the-art magnetic sensors based on its patented XtremeSense® TMR sensor technology. Crocus’ disruptive magnetic sensor technology brings significant advancements to IoT and smart devices, industrial, consumer, medical, and automotive electronics applications demanding high accuracy, high resolution, stable temperature performance, and low power consumption. Crocus is headquartered in Santa Clara, California. For more information, please visit http://www.crocus-technology.com.

© 2021 Crocus Technology International Corp. All rights reserved. Crocus Technology, XtremeSense® and combinations thereof are trademarks of Crocus Technology Inc. and Crocus Technology SA. Other names are for informational purposes only and may be trademarks of their respective owners.

For more information, please contact:

Elsa Magnani
Crocus Technology
Tel: +1-208-999-6643
Email: emagnani@crocus-technology.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Baltic Horizon Fund consolidated audited results for 202329.3.2024 10:35:00 CET | Press release

Management Board of Northern Horizon Capital AS has approved the audited financial results of Baltic Horizon Fund (the Fund) for the year 2023. The financial results remained unchanged compared to the preliminary disclosure on 15 February 2024. Executing our strategy In a challenging economic landscape characterized by inflation, interest rate volatility, and recent geopolitical events, the Fund has assessed various strategic options to navigate these complexities and ensure future growth. Over the past year, our focus has been on reshaping our strategy to foster sustainable value, concentrating efforts on avenues that promise reliable and consistent growth for our investors. In light of prevailing market conditions, we firmly believe that the execution of the ‘Modern City Life’ strategy, introduced to investors in summer 2023, is paramount to their best interests. In the coming years, we expect two thirds of the Fund’s NOI to come from the centrally located ‘Modern City Life’ multi-fu

Progress on ABN AMRO share buyback programme 22 – 28 March 202429.3.2024 08:00:00 CET | Press release

Progress on ABN AMRO share buyback programme 22 – 28 March 2024 ABN AMRO reports the transaction details related to its EUR 500 million share buyback programme announced on 14 February 2024. During the week of 22 March 2024 up to and including 28 March 2024 a total of 3,000,000 shares and depositary receipts were repurchased at an average price of €15.47 for a total amount of €46,409,760.00. For detailed information on the daily repurchased shares and depositary receipts, individual share purchase transactions and weekly reports, see the ABN AMRO website at https://www.abnamro.com/en/investor-relations/information/share-buyback-programme. To date the total consideration for shares and depositary receipts repurchased amounts to €279,519,000.00 representing 55.9% of the overall share buyback programme. ABN AMRO Press Office pressrelations@nl.abnamro.com +31 20 6288900ABN AMRO Investor Relations investorrelations@nl.abnamro.com +31 20 6282282 This press release is published by ABN AMRO Ba

Public announcement in accordance with article 7:97, §4/1 of the Belgian Companies and Associations Code (“BCAC”) concerning a capital increase by contribution in kind29.3.2024 07:00:00 CET | Press release

Press release Brussels, 29 March 2024 Regulated information – Inside information Public announcement in accordance with article 7:97, §4/1 of the Belgian Companies and Associations Code (“BCAC”) concerning a capital increase by contribution in kind On 20 November 2023, Orange Belgium SA (the “Company”) received notification from Nethys SA (“Nethys”) of its wish to contribute its 25% + 1 shareholding in VOO Holding SA (“VOO”) to the capital of the Company, provided that such contribution results in Nethys holding at least 11% of the Company's share capital (after contribution), pursuant to the provisions of the shareholders' agreement entered into by and between the Company, Atlas Services Belgium SA (“ASB”) and Nethys on 2 June 2023. Nethys can be considered a “related” party to the Company within the meaning of the IAS standards, as it has significant influence over VOO within the meaning of IAS and VOO is part of the group to which the Company belongs. Date and value of the planned t

McWhorter Foundation Combats Nelson Peltz’s Outdated Ideologies and Advocates for Sustainable Inclusivity In Corporate Leadership29.3.2024 06:59:56 CET | Press release

PALM BEACH, Calif., March 29, 2024 (GLOBE NEWSWIRE) -- C.K. McWhorter, chairman of the McWhorter Foundation, voices concerns over outdated perspectives in corporate leadership, exemplified by recent remarks from Nelson Peltz regarding Disney's film direction. After encountering instances of racism and exclusivity on Town of Palm Beach Island (known as home to Jeffrey Epstein, Nelson Peltz and others), McWhorter reflects on the disconnect between elite boardroom discussions and the realities faced by diverse communities. While briefly meeting Nelson Peltz and shaking hands after both departed separate lunches, McWhorter initially respected his insights. However, recent comments made by Peltz suggesting Disney should avoid inclusive films have raised eyebrows and prompted McWhorter to speak out. "It's concerning when influential figures like Peltz advocate against inclusivity in entertainment," McWhorter comments. "The future is in diversity and representation, especially as millennial a

Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates29.3.2024 05:24:27 CET | Press release

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2023 and provided corporate updates. FINANCIAL HIGHLIGHTS Total revenue was approximately RMB1,503 million during 2023. The revenue from pharmaceutical products increased by approximately 58% compared to 2022. The sales revenue of TUOYI® (toripalimab) was approximately RMB919 million, representing an increase of approximately 25% compared to the previous year.Total research and development (“R&D”) expenses were approximately RMB1,937 million in 2023, representing a decrease of approximately 19% compared to 2022. The decrease in R&D expenses was mainly due to the strategic management of R&D investments in certain early-stage pipelines, while optimizing resource all

HiddenA line styled icon from Orion Icon Library.Eye